04 Jun 2024
The BSPED Growth Disorders Special Interest group (SIG) is delighted to share two new related documents recently approved by the BSPED clinical committee:
The aim of this recommendation document is to guide UK paediatric endocrinologists considering the use of rhIGF-I for severe primary IGF-I deficiency (SPIGFD).
This recommendation aims to guide UK paediatric endocrinologists who are considering the use of rhIGF-I for severe insulin resistance syndromes (SIR) secondary to insulin receptoropathies.
New research identifies rare genes behind early menopause
13 Sept 2024
Night owls more likely to develop type 2 diabetes
12 Sept 2024
New weight loss pill outperforms Wegovy in early trials
12 Sept 2024
Virtual peer review – ensure your centre has an up to date review and get involved as a reviewer
06 Sept 2024
NICE guideline on adrenal insufficiency: identification and management
06 Sept 2024